|
Q4 FY2021
As of Nov 30, 2021
|
|
|---|---|
| ASSETS | |
| Current | |
| Cash | |
| Marketable securities and derivatives | |
| Trade and other receivables | |
| Prepaid expenses and other current assets | |
| Promissory note receivable | |
| Income tax receivable | |
| Indemnity assets | |
| Inventory | |
| Biological assets | |
| Current assets | |
| Non-Current | |
| Property, plant and equipment | |
| Intangible assets | |
| Goodwill | |
| TOTAL ASSETS | |
| LIABILITIES AND SHAREHOLDERS' EQUITY | |
| Current | |
| Accounts payable and accrued liabilities | |
| Term loan and other debt - current | |
| Contractual obligation - current | |
| Lease liabilities - current | |
| Contingent consideration - current | |
| Other liability | |
| Current liabilities | |
| Non-Current | |
| Term loan and other debt | |
| Contractual obligation | |
| Lease liabilities | |
| Contingent consideration | |
| Deferred tax liability | |
| Liabilities | |
| Shareholders' equity | |
| Share capital | |
| Reserves | |
| Obligation to issue shares | |
| Accumulated other comprehensive income | |
| Deficit | |
| Shareholders' equity | |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY |
Loading...
